Cargando…

The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy

Genital warts/condyloma acuminata is the most common mucosal human papillomavirus (HPV) infection encountered by the dermatologists. They can be asymptomatic or symptomatic. They can present as discrete lesions or confluent masses. Depending on the HPV strains, lesions can either be benign or may tu...

Descripción completa

Detalles Bibliográficos
Autor principal: Gupta, Sunil Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000664/
https://www.ncbi.nlm.nih.gov/pubmed/33817597
http://dx.doi.org/10.4103/ijstd.IJSTD_62_19
_version_ 1783671049344253952
author Gupta, Sunil Kumar
author_facet Gupta, Sunil Kumar
author_sort Gupta, Sunil Kumar
collection PubMed
description Genital warts/condyloma acuminata is the most common mucosal human papillomavirus (HPV) infection encountered by the dermatologists. They can be asymptomatic or symptomatic. They can present as discrete lesions or confluent masses. Depending on the HPV strains, lesions can either be benign or may turn malignant. The treatment modalities for genital warts range from topical, systemic, intralesional immunotherapy, and surgical interventions (intralesional immunotherapy has shown promising results in the treatment of viral and genital warts). However, there are very few reports that have used Bacillus Calmette–Guérin (BCG) as immunotherapy in genital warts. Here, we report, in author's opinion, the first case of female vulvovaginal warts successfully treated with intralesional BCG immunotherapy, leading to complete resolution of injected warts as well as near-distant warts.
format Online
Article
Text
id pubmed-8000664
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-80006642021-04-01 The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy Gupta, Sunil Kumar Indian J Sex Transm Dis AIDS Case Reports Genital warts/condyloma acuminata is the most common mucosal human papillomavirus (HPV) infection encountered by the dermatologists. They can be asymptomatic or symptomatic. They can present as discrete lesions or confluent masses. Depending on the HPV strains, lesions can either be benign or may turn malignant. The treatment modalities for genital warts range from topical, systemic, intralesional immunotherapy, and surgical interventions (intralesional immunotherapy has shown promising results in the treatment of viral and genital warts). However, there are very few reports that have used Bacillus Calmette–Guérin (BCG) as immunotherapy in genital warts. Here, we report, in author's opinion, the first case of female vulvovaginal warts successfully treated with intralesional BCG immunotherapy, leading to complete resolution of injected warts as well as near-distant warts. Wolters Kluwer - Medknow 2020 2020-07-31 /pmc/articles/PMC8000664/ /pubmed/33817597 http://dx.doi.org/10.4103/ijstd.IJSTD_62_19 Text en Copyright: © 2020 Indian Journal of Sexually Transmitted Diseases and AIDS http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Reports
Gupta, Sunil Kumar
The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
title The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
title_full The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
title_fullStr The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
title_full_unstemmed The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
title_short The management of vulvovaginal warts using intralesional Bacillus Calmette–Guérin immunotherapy
title_sort management of vulvovaginal warts using intralesional bacillus calmette–guérin immunotherapy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000664/
https://www.ncbi.nlm.nih.gov/pubmed/33817597
http://dx.doi.org/10.4103/ijstd.IJSTD_62_19
work_keys_str_mv AT guptasunilkumar themanagementofvulvovaginalwartsusingintralesionalbacilluscalmetteguerinimmunotherapy
AT guptasunilkumar managementofvulvovaginalwartsusingintralesionalbacilluscalmetteguerinimmunotherapy